AU8145587A - Unsaturated phosphonic acids and derivatives - Google Patents

Unsaturated phosphonic acids and derivatives

Info

Publication number
AU8145587A
AU8145587A AU81455/87A AU8145587A AU8145587A AU 8145587 A AU8145587 A AU 8145587A AU 81455/87 A AU81455/87 A AU 81455/87A AU 8145587 A AU8145587 A AU 8145587A AU 8145587 A AU8145587 A AU 8145587A
Authority
AU
Australia
Prior art keywords
carbon
carboxyl
derivatives
compounds
membered ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU81455/87A
Other versions
AU610841B2 (en
Inventor
Alan J. Hutchison
Josef A. Schneider
Kenneth R. Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU8145587A publication Critical patent/AU8145587A/en
Application granted granted Critical
Publication of AU610841B2 publication Critical patent/AU610841B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Dental Preparations (AREA)

Abstract

Compounds of the formula I <IMAGE> in which one or both of the acidic hydroxyl groups of the phosphonic acid part can be etherified, m is one or zero, R<1> denotes carboxyl, esterified carboxyl or amidated carboxyl, the heterocyclic five- or six-membered ring can additionally be substituted on the carbon and/or nitrogen, can have a carbon-carbon double bond or can be condensed with a carbocyclic 6-membered ring, starting from adjacent carbon atoms, A represents lower alkenylene; and salts thereof. These compounds are suitable as antagonists of the N-methyl-D-aspartate- sensitive amino acid stimulant receptor in mammals.
AU81455/87A 1986-11-21 1987-11-20 Unsaturated phosphonic acids and derivatives Ceased AU610841B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93370286A 1986-11-21 1986-11-21
US933702 1986-11-21

Publications (2)

Publication Number Publication Date
AU8145587A true AU8145587A (en) 1988-05-26
AU610841B2 AU610841B2 (en) 1991-05-30

Family

ID=25464377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81455/87A Ceased AU610841B2 (en) 1986-11-21 1987-11-20 Unsaturated phosphonic acids and derivatives

Country Status (21)

Country Link
EP (1) EP0275820B1 (en)
JP (1) JPH0686470B2 (en)
KR (1) KR880006195A (en)
AT (1) ATE60776T1 (en)
AU (1) AU610841B2 (en)
CA (1) CA1312608C (en)
DD (1) DD273837A5 (en)
DE (1) DE3768000D1 (en)
DK (1) DK609487A (en)
ES (1) ES2031927T3 (en)
FI (1) FI86638C (en)
GR (1) GR3001443T3 (en)
HU (1) HU199857B (en)
IE (1) IE60534B1 (en)
IL (1) IL84492A0 (en)
MX (1) MX9437A (en)
NO (1) NO170853C (en)
NZ (1) NZ222607A (en)
PH (1) PH25465A (en)
PT (1) PT86168B (en)
ZA (1) ZA878699B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
US5194430A (en) * 1990-05-17 1993-03-16 Merrell Dow Pharmaceuticals Inc. Heterocyclic-nmda antagonists
SE9003652D0 (en) * 1990-11-15 1990-11-15 Astra Ab NEW HETEROCYCLIC COMPOUNDS
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
NZ501714A (en) 1997-06-12 2001-09-28 Rhone Poulenc Rorer Ltd Imidazolyl-cyclic acetal derivatives, resins and intermediates thereof and use as TNF inhibitors
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals

Also Published As

Publication number Publication date
KR880006195A (en) 1988-07-22
FI875097A0 (en) 1987-11-18
GR3001443T3 (en) 1992-09-25
PH25465A (en) 1991-07-01
MX9437A (en) 1994-01-31
JPH01135791A (en) 1989-05-29
FI86638C (en) 1992-09-25
EP0275820A2 (en) 1988-07-27
AU610841B2 (en) 1991-05-30
PT86168B (en) 1990-08-31
ZA878699B (en) 1988-05-23
NO170853B (en) 1992-09-07
HU199857B (en) 1990-03-28
IE873149L (en) 1988-05-21
PT86168A (en) 1987-12-01
NO874854L (en) 1988-05-24
NZ222607A (en) 1990-10-26
IE60534B1 (en) 1994-07-27
ATE60776T1 (en) 1991-02-15
NO170853C (en) 1992-12-16
ES2031927T3 (en) 1993-01-01
DK609487D0 (en) 1987-11-20
EP0275820B1 (en) 1991-02-06
DE3768000D1 (en) 1991-03-14
FI875097A (en) 1988-05-22
NO874854D0 (en) 1987-11-20
HUT46331A (en) 1988-10-28
EP0275820A3 (en) 1988-08-03
FI86638B (en) 1992-06-15
CA1312608C (en) 1993-01-12
JPH0686470B2 (en) 1994-11-02
IL84492A0 (en) 1988-04-29
DD273837A5 (en) 1989-11-29
DK609487A (en) 1988-05-22

Similar Documents

Publication Publication Date Title
AU5784686A (en) Certain phosphonic acids and derivatives
AU8145587A (en) Unsaturated phosphonic acids and derivatives
FI881892A (en) Process for the preparation of novel therapeutically useful 1,2,5,6-tetrahydropyridine derivatives
SE8200570L (en) TIAZOLIDE INGREDIENTS WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR PREPARING THEREOF
AU584336B2 (en) New cephalosporins and processes for their preparation
ES2076369T3 (en) PROCEDURE FOR THE SEPARATION OF RACEMATES OF ESTERS OF 4-ARYL-2-OXO-PIRROLIDINE-3-CARBOXYLIC ACIDS.
ES2053868T3 (en) 3-AMINOSIDNONIMINAS SUBSTITUTED, PROCEDURES FOR ITS OBTAINING AND ITS EMPLOYMENT.
ES2000369A6 (en) Substituted DI-t-butylphenols.